Medlab Clinical talks upcoming Phase III NanaBis trial and NanoCelle partnering opportunities -Dr Sean Hall, CEO, Medlab Clinical Ltd 00:00:00

Share On Facebook Share On Twitter

Medlab Clinical Ltd's (ASX:MDC) Dr Sean Hall tells Proactive's Andrew Scott they're focused on achieving regulatory approval for its lead drug candidate NanaBis

Recent Videos